Tracy Cunningham

Direttore Tecnico/Scientifico/R&S presso AMRYT PHARMA PLC

Health Technology

Consumer Services

Government

Posizioni attive di Tracy Cunningham

Società	Posizione	Inizio	Fine
AMRYT PHARMA PLC	Direttore Tecnico/Scientifico/R&S	01/04/2020	-
Health Research Board	Direttore/Membro del Consiglio	-	-

Società	Posizione	Inizio	Fine
ASTRAZENECA PLC	Corporate Officer/Principal	-	-
Amryt Pharma Holdings Ltd. Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom.	Direttore Tecnico/Scientifico/R&S	27/06/2022	-
	Corporate Officer/Principal	01/04/2020	27/06/2022

Royal College of Surgeons

Undergraduate Degree

Distribuzione geografica

Irlanda	4
Regno Unito	3

Posizioni

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	2
Undergraduate Degree	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
ASTRAZENECA PLC	Health Technology

Aziende private	3
Health Research Board	Government
Amryt Pharma Holdings Ltd. Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom.	Health Technology
Amryt Pharma Plc Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Amryt Pharma Plc operates as a holding company with interests in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The company was founded on July 17, 2019 and is headquartered in Dublin, Ireland.	Health Technology